Sunday

25th Feb 2018

Analysis

'Think of the patients!' cry EU agency contenders

  • The EMA evaluates if medicines are safe (Photo: Grumpy-Puddin)

Does the future home of the European Medicines Agency matter to patient safety?

The cry '...but think of the children!' has often been used seriously in politics - but also satirically, in TV series like the Simpsons.

Thank you for reading EUobserver!

Subscribe now for a 30 day free trial.

  1. €150 per year
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

  • Will patients be at risk if the 'wrong' city is chosen to host EMA? (Photo: Helena Spongenberg)

Now, a variation on the theme has been used in earnest in the past few months by European ministers, in the debate about which city is best equipped to host the London-based European Medicines Agency (EMA).

The EMA has to find a new home after Brexit, and nineteen member states have offered to host it.

"Ladies and gentlemen, millions of Europeans depend on the availability of high-quality, effective, safe medicine," said Dutch health minister Edith Schippers last July, when promoting the bid for Amsterdam.

"Think of the many people with chronic diseases, who can live good and productive lives thanks to their medication," she said.

"Think of all those patients with cancer that have an ever-increasing chance of survival, thanks to innovative treatments and medication. The same is true for people with rare diseases. They are looking at us politicians. Can we ensure their access to the treatments they need?"

Spanish health minister Dolors Montserrat said the same thing, when she came to Brussels in May to argue why Barcelona was "the best city" to host the EMA.

She also referred to the argument - made by some EU member states that currently do not host any EU agency - that the offices should be distributed evenly.

Montserrat told EUobserver that whether a member state already has an agency should not be relevant to the decision on where to relocate EMA.

"We have to think of the health of the European patients," she said, noting that some candidate cities "perhaps" did not have the best infrastructure, international schools, or an airport with frequent flights to European capitals.

"So we have to save the health of the European citizens. .. We have to do a smooth relocation," she said.

Unspoken criticism

The phrase 'smooth relocation' has been uttered by most of Montserrat's counterparts from the other competing member states in the past half year.

The unspoken accusation in the words of these health ministers is of course that a relocation to the city of some of the candidates would lead to a potential health risk, maybe even leading to deaths.

So is there such a risk?

Smooth relocation

The EMA is responsible for evaluating the safety of medicines for humans as well as for other animals.

As of last week, the EMA had given 75 positive opinions on new medicines this year, and five negative opinions.

Belgian health minister Maggie De Block told EUobserver earlier this month that there should be no "disruptive effect" during the agency's move from London to the new host city.

"Otherwise this would mean that patients will have access to new medication later than normal," she said. "So for some people that medication will arrive too late. That would be a disaster."

However, De Block would not say if any of the candidate countries, if selected, would lead to such a disastrous scenario.

"We keep it fair," she said. "May the best [candidate] win."

Helsinki mayor Jan Vapaavuori, promoting his city's bid, also declined to answer.

"You asked about the worst case scenario. We do not comment [on] that. We only know what's the best case scenario," he said.

Clinical trials

Health minister Konstanty Radziwill did make an allusion to countries who do not fit the criteria, albeit indirectly.

Radziwill noted in an interview with EUobserver that in Poland between 30,000 and 40,000 citizens are involved in clinical trials annually.

"We have a population of 38 million. If the population is much, much smaller, this is impossible," he said.

But according to a health expert from one of the countries with the smallest populations in the race to host the EMA, that argument is invalid.

"The number of individuals included in clinical trials in the host country has no relevance for the relocation of the EMA," said Sinisa Tomic, head of the Croatian medicines agency.

Croatia has a population of 4.2 million. Its capital Zagreb is a candidate.

"Companies perform clinical trials all over the world and bring their results to the EMA in order to obtain approval for their medicinal products," Tomic told EUobserver via email.

The authorisation of clinical trials takes place at the national level, not the EU level.

Some member states had hoped that the European Commission would make a shortlist, or at least some ranking of the different bids.

However, its assessment of the bids, published last month, was extremely factual.

For example, in the commission's discussion of the criterion "business continuity", the EU's executive refrained from giving a value judgement, or any fact-checking of statements made.

Risk of 'permanent damage'

But the European Medicines Agency itself was much more direct.

Days after the commission had presented its document, the EMA published an assessment of the bids, which did include preferences, and criteria.

It also warned that many staff members were considering leaving the agency, depending on the city chosen.

In the best case scenario – a choice for Amsterdam, Barcelona, Copenhagen, Milan, or Vienna – between 19 percent and 35 percent of staff said they would "likely" or "very likely" quit.

This would lead to the approval of new medicines being "largely maintained", EMA said, although it noted there would still be the "possibility of delays". The agency would then need between two and three years to fully recover from the move.

But if EMA would move to Athens, Bratislava, Bucharest, Helsinki, Malta, Sofia, Warsaw, or Zagreb, between 72 and 94 percent of staff said they would probably leave the agency.

If that were to happen, this would lead to "permanent damage to the system" and an "unravelling of the EU single market for medicines". In that scenario, EMA expects some medicines to become unavailable and a need to import from outside the EU, mainly Japan and the US.

Moreover, in that scenario, EMA expected patients to be "exposed to side effects – deaths – litigation".

Of course, what EMA staff said in the survey they would do, is not necessarily what they will actually do.

Once a decision has been made for a city, personnel will probably make another weighing: do I really want to quit my job, or can I still have a good life in this new city?

The conundrum is that there is no scientific method to determine how many staff will actually leave – the real staff loss will not be known until a city has been chosen, when it will be too late for a minister to change their mind.

On Tuesday (17 October), interior and EU affairs ministers will discuss the bids at a meeting in Luxembourg.

It is unlikely a decision will be made this week.

Rather, it is expected that the next ministerial meeting of that format, now scheduled for 20 November, will see up to three rounds of voting to determine the new seat of the EMA.

Read more on EU agencies in EUobserver's 2017 Regions & Cities Magazine.

Click here to access EUobserver's entire magazine collection.

EU medicines agency reveals new home preferences

Staff said they preferred to move to Amsterdam, Barcelona, Copenhagen, Milan, or Vienna. More than 70% said they would quit if the agency moved to Athens, Bratislava, Bucharest, Helsinki, Malta, Sofia, Warsaw, or Zagreb.

Magazine

The EU Agencies Race

In this edition of EUobserver's Regions & Cities magazine, we take a closer look at some of the EU agencies, exploring how their location matters and the benefits for cities and regions to host them.

EU agency bids assessment brings 'nothing new'

The commission said it did not have time to look beyond the documents each of the contending member states sent to the Council of the EU, which were already public.

Leaders lobby on EU agencies in summit margins

The official agenda point on where to relocate the EU medicines and banking agencies after Brexit was over in "one minute", but lobbying took place in the corridors.

Opinion

Intellectual property protection - the cure for Europe's ills

The European Commission is considering rolling back medical research incentives, on the faulty assumption they are somehow driving higher drug prices. But not only is that premise flawed – the proposed fix will do nothing to benefit ordinary health consumers.

Supported by

News in Brief

  1. EU calls for immediate ceasefire in Syria
  2. UK's post-Brexit vision is 'pure illusion', Tusk says
  3. EU leaders express solidarity with Cyprus in Turkey drill row
  4. EU to double funding for Sahel forces
  5. EU parliament president: 'The immigration problem is Africa'
  6. May to unveil EU departure strategy next week
  7. Pregnant workers may be dismissed, EU court rules
  8. Romanian minister demands anti-corruption prosecutor fired

Stakeholders' Highlights

  1. ILGA EuropeAnkara Ban on LGBTI Events Continues as Turkish Courts Reject NGO Appeals
  2. Aid & Trade LondonJoin Thousands of Stakeholders of the Global Aid Industry at Aid & Trade London
  3. Macedonian Human Rights Movement Int.European Free Alliance Joins MHRMI to End the Anti-Macedonian Name Negotiations
  4. Mission of China to the EUChina-EU Tourism Year to Promote Business and Mutual Ties
  5. European Jewish CongressAt “An End to Antisemitism!” Conference, Dr. Kantor Calls for Ambitious Solutions
  6. UNESDAA Year Ago UNESDA Members Pledged to Reduce Added Sugars in Soft Drinks by 10%
  7. International Partnership for Human RightsUzbekistan: Investigate Torture of Journalist
  8. CESICESI@Noon on ‘Digitalisation & Future of Work: Social Protection For All?’ - March 7
  9. UNICEFExecutive Director's Committment to Tackling Sexual Exploitation and Abuse of Children
  10. Nordic Council of MinistersState of the Nordic Region 2018: Facts, Figures and Rankings of the 74 Regions
  11. Mission of China to the EUDigital Economy Shaping China's Future, Over 30% of GDP
  12. Macedonian Human Rights Movement Int.Suing the Governments of Macedonia and Greece for Changing Macedonia's Name

Latest News

  1. EU agrees budget to focus on defence, security and migration
  2. EU leaders nix transnational lists, cool on 'Spitzenkandidat'
  3. Regions chief: calls for smaller EU budget are 'impossible'
  4. Election fever picks up This WEEK
  5. EU-Morocco fishing deal casts doubt on EU future foreign policy
  6. EU leaders put 'Spitzenkandidat' on summit menu
  7. European far-right political party risks collapse
  8. The key budget issues on EU leaders' table

Stakeholders' Highlights

  1. Swedish EnterprisesHarnessing Globalization- at What Cost? Keynote Speaker Commissioner Malmström
  2. European Friends of ArmeniaSave The Date 28/02: “Nagorno-Karabakh & the EU: 1988-2018”
  3. European Heart NetworkSmart CAP is Triple Win for Economy, Environment and Health
  4. European Free AlllianceEFA Joined the Protest in Aiacciu to Solicit a Dialogue After the Elections
  5. EPSUDrinking Water Directive Step Forward but Human Right to Water Not Recognized
  6. European Gaming & Betting AssociationGambling Operators File Data Protection Complaint Against Payment Block in Norway
  7. European Jewish CongressEJC Expresses Deep Concern Over Proposed Holocaust Law in Poland
  8. CECEConstruction Industry Gets Together to Discuss the Digital Revolution @ the EU Industry Days
  9. Mission of China to the EUChina-EU Relations in the New Era
  10. European Free AlllianceEnd Discrimination of European Minorities - Sign the Minority Safepack Initiative
  11. Centre Maurits Coppieters“Diversity Shouldn’t Be Only a Slogan” Lorant Vincze (Fuen) Warns European Commission
  12. Dialogue PlatformWhat Can Christians Learn from a Global Islamic Movement?

Stakeholders' Highlights

  1. European Jewish CongressEJC President Warns Europe as Holocaust Memory Fades
  2. European Free AlllianceNo Justice From the Spanish Supreme Court Ruling
  3. Nordic Council of MinistersNordic Solutions for Sustainable Cities: New Grants Awarded for Branding Projects
  4. Mission of China to the EUTrade Between China, Belt and Road Countries up 15%
  5. Nordic Council of MinistersOresund Inspires Other EU Border Regions to Work Together to Generate Growth
  6. Mission of China to the EUTrade Between China, Belt and Road Countries up 15%
  7. AJC Transatlantic InstituteAJC Calls on EU to Sanction Iran’s Revolutionary Guards, Expel Ambassadors
  8. ILGA EuropeFreedom of Movement and Same-Sex Couples in Romania – Case Update!
  9. EU2017EEEstonia Completes First EU Presidency, Introduced New Topics to the Agenda
  10. Bio-Based IndustriesLeading the Transition Towards a Post-Petroleum Society